3rd Department of Internal Medicine, Landesklinikum St Pölten, 3100 St Pölten, Austria, Europe.
Am J Emerg Med. 2011 Jun;29(5):534-40. doi: 10.1016/j.ajem.2009.12.016. Epub 2010 May 1.
Pharmacologic cardioversion of atrial fibrillation (AF) is a reasonable mode of treatment if the arrhythmia is of recent onset. Results concerning the response rates of different drugs, respectively, in daily clinical practice and data with regard to the parameters associated with successful cardioversion are not very prevalent.
Three-hundred seventy-six patients who were admitted to the emergency department with acute AF and a duration of shorter than 48 hours were enrolled into the AF registry.
The most effective drugs were flecainide and ibutilide (95% and 76%). Low response rates were observed with amiodarone (36%) and the individual use of digoxin or diltiazem (19% and 18%). Factors associated with a successful cardioversion were a lower blood pressure on admission (P = .002), a shorter time interval between the onset of AF and admission to the ED (P = .003), and adherence to treatment guidelines (P < .0001).
The use of flecainide and ibutilide is associated with a much higher rate of cardioversion than other drugs we studied.
如果心律失常是新近发生的,药物复律是治疗心房颤动(AF)的合理方式。在日常临床实践中,不同药物的反应率以及与成功复律相关的参数数据并不常见。
将 376 名因急性 AF 且持续时间短于 48 小时而入住急诊科的患者纳入 AF 登记处。
最有效的药物是氟卡尼和伊布利特(95%和 76%)。胺碘酮(36%)和单独使用地高辛或地尔硫䓬(19%和 18%)的反应率较低。与成功复律相关的因素包括入院时血压较低(P =.002)、AF 发作到急诊科就诊的时间间隔较短(P =.003)以及遵循治疗指南(P <.0001)。
与我们研究的其他药物相比,氟卡尼和伊布利特的使用与更高的复律率相关。